Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G A van Dongen

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 4, 1998
Prospects for future studies in head and neck cancerG A van Dongen, G B Snow
Tijdschrift Voor Gerontologie En Geriatrie|June 1, 1989
[Homes for the aged: a source of increasing concern (4). The evaluation of a group care program]C M van Loveren-Huyben, G A van Dongen
Analytical Biochemistry|May 1, 1994
Optimization and simplification of expression cloning in eukaryotic vector/host systemsR H Brakenhoff, E M Knippels, G A van Dongen
Cancer Research|January 1, 1991
Preclinical in vivo activity of 2',2'-difluorodeoxycytidine (Gemcitabine) against human head and neck cancerB J Braakhuis, G A van Dongen, J B Vermorken, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|January 1, 1990
Comparative study of the sensitivity of head and neck cell lines to methotrexate (MTX) and the analog 10-ethyl, 10-deazaaminopterin (10-EdAM)D H Brown, B J Braakhuis, G A Van Dongen, et al.
Cancer Immunology, Immunotherapy : CII|April 1, 1997
Rapid elimination of mouse/human chimeric monoclonal antibodies in nude miceF B van Gog, R H Brakenhoff, G B Snow, et al.
European Journal of Cancer. Part B, Oral Oncology|January 1, 1994
The feasibility of radioimmunotherapy of head and neck cancerM Gerretsen, J J Quak, R H Brakenhoff, et al.
Investigational New Drugs|December 1, 1988
Preclinical antitumor activity of 5-aza-2'-deoxycytidine against human and neck cancer xenografts [corrected]B J Braakhuis, G A van Dongen, M van Walsum, et al.
International Journal of Cancer|June 9, 1995
Natural killer (NK) cells as effectors of antibody-dependent cytotoxicity with chimeric antibodies reactive with human squamous-cell carcinomas of the head and neckM W Sung, S Yasumura, J T Johnson, et al.
Cellular Immunology|July 10, 1996
The role of apoptosis in antibody-dependent cell-mediated cytotoxicity against monolayers of human squamous cell carcinoma of the head and neck targetsM W Sung, S Nagashima, J T Johnson, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 4, 1998
Prospects for future studies in head and neck cancerG A van Dongen, G B Snow
Tijdschrift Voor Gerontologie En Geriatrie|June 1, 1989
[Homes for the aged: a source of increasing concern (4). The evaluation of a group care program]C M van Loveren-Huyben, G A van Dongen
Analytical Biochemistry|May 1, 1994
Optimization and simplification of expression cloning in eukaryotic vector/host systemsR H Brakenhoff, E M Knippels, G A van Dongen
Cancer Research|January 1, 1991
Preclinical in vivo activity of 2',2'-difluorodeoxycytidine (Gemcitabine) against human head and neck cancerB J Braakhuis, G A van Dongen, J B Vermorken, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|January 1, 1990
Comparative study of the sensitivity of head and neck cell lines to methotrexate (MTX) and the analog 10-ethyl, 10-deazaaminopterin (10-EdAM)D H Brown, B J Braakhuis, G A Van Dongen, et al.
Cancer Immunology, Immunotherapy : CII|April 1, 1997
Rapid elimination of mouse/human chimeric monoclonal antibodies in nude miceF B van Gog, R H Brakenhoff, G B Snow, et al.
European Journal of Cancer. Part B, Oral Oncology|January 1, 1994
The feasibility of radioimmunotherapy of head and neck cancerM Gerretsen, J J Quak, R H Brakenhoff, et al.
Investigational New Drugs|December 1, 1988
Preclinical antitumor activity of 5-aza-2'-deoxycytidine against human and neck cancer xenografts [corrected]B J Braakhuis, G A van Dongen, M van Walsum, et al.
International Journal of Cancer|June 9, 1995
Natural killer (NK) cells as effectors of antibody-dependent cytotoxicity with chimeric antibodies reactive with human squamous-cell carcinomas of the head and neckM W Sung, S Yasumura, J T Johnson, et al.
Cellular Immunology|July 10, 1996
The role of apoptosis in antibody-dependent cell-mediated cytotoxicity against monolayers of human squamous cell carcinoma of the head and neck targetsM W Sung, S Nagashima, J T Johnson, et al.
Pageof 6